Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Implant Sciences System Could Address Gamma Radiation Safety Concerns

This article was originally published in The Gray Sheet

Executive Summary

Implant Sciences feels its "soft" gamma ray-emitting system for the prevention of restenosis following coronary angioplasty is capable of overcoming hospital personnel safety concerns associated with similar brachytherapy systems.

You may also be interested in...

Novsoste BetaCath Shows Zero Rate Of Late-Stent Thrombosis START Trial

Novoste Corp. appears poised for a smooth path to FDA approval for the BetaCath beta radiation system, given the 0% incidence of late-stent thrombosis in treating patients for in-stent restenosis.

Gamma System Late Thrombosis Concern Mitigated By Outside Data - Cordis

Johnson & Johnson Cordis is hoping for a chance to make its case before FDA's Circulatory System Devices Panel that FDA should consider data neither generated by the company nor included in the premarket approval application for its Gamma brachytherapy system for treatment of coronary artery restenosis.

J&J's Gamma Brachytherapy System Effectively Reduces Restenosis - TCT

Physicians treating in-stent restenosis with intravascular brachytherapy should avoid placing new stents at the time of radiation, Paul Teirstein, MD, Scripps Clinic, La Jolla, California cautioned in a Sept. 23 release announcing the results of the Johnson & Johnson GAMMA I trial.

Related Content




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts